| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/25/2011 | US7875441 hybridization assay probes, helper probes, and/or amplification primers; kits |
| 01/25/2011 | US7875440 Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
| 01/25/2011 | US7875436 immobilization; solid phase synthesis; kits |
| 01/25/2011 | US7875432 Method for diagnosing spinal muscular atrophy |
| 01/25/2011 | US7875431 in gastrointestinal tissues or cells of mammal by detecting increased expression of LY6 genes |
| 01/25/2011 | US7875430 Using transposon specific probe to identify insertional events in maize that confer insect resistance; biological pest control |
| 01/25/2011 | US7875429 Corn event DAS-59122-7 and methods for detection thereof |
| 01/25/2011 | US7875428 human papillomavirus (HPV); biochips; genotyping |
| 01/25/2011 | US7875427 Compositions and methods for IL-13 biomarkers |
| 01/25/2011 | US7875426 DNA biochip and methods of use |
| 01/25/2011 | US7875425 Methods for monitoring polymerase chain reactions |
| 01/25/2011 | US7875424 Identification of tumour-associated cell surface antigens for diagnosis and therapy |
| 01/25/2011 | US7875423 hepatitis b virus (HBV) variants with reduced sensitivity to agents and/or reduced interactivity with immunological reagents; detecting adefovir dipivoxil resistance |
| 01/25/2011 | US7875422 Viral drug susceptibility testing |
| 01/25/2011 | US7875421 determining probiotic properties |
| 01/25/2011 | US7875293 Biointerface membranes incorporating bioactive agents |
| 01/25/2011 | US7875274 identifying therapeutically responsive phenotype in brain tumor cells by measuring expression of TNFAIP3 gene (tumor necrosis factor alpha-induced protein 3) |
| 01/25/2011 | US7875261 Staining; for detecting reactive oxygen species such as hydrogen peroxide; used in immunology, diagnostics, molecular biology and fluorescence based assays |
| 01/25/2011 | US7874128 Test unit and method for testing whether a sterilizing packaging unit is effective against recontamination, and container packaging suitable for applying said method |
| 01/25/2011 | CA2529965C Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases |
| 01/25/2011 | CA2529579C Biosensor with multiple electrical functionalities |
| 01/25/2011 | CA2526847C Assay and kits for detecting protein binding |
| 01/25/2011 | CA2462649C System for the detection of urease and method for using same |
| 01/25/2011 | CA2458842C Plant system for comprehensive gene function analysis with the use of full-length cdnas |
| 01/25/2011 | CA2417648C Inactivation of antimicrobial agents by a phospholipid or a nonionic surfactant in methods of quantifying microorganisms |
| 01/25/2011 | CA2378190C Microfabricated elastomeric valve and pump systems |
| 01/25/2011 | CA2344467C Ucp4 |
| 01/25/2011 | CA2321089C Human homolog of the drosophila protein "fused" |
| 01/25/2011 | CA2174098C Method of inducing and maintaining neuronal cells |
| 01/22/2011 | CA2690651A1 Preservation of fetal nucleic acids in maternal plasma |
| 01/20/2011 | WO2011009114A2 Methods and kits used in assessing cancer risk |
| 01/20/2011 | WO2011009099A1 Metabolic biomarkers of crohn's disease |
| 01/20/2011 | WO2011009073A1 A method for amplification of nucleic acids |
| 01/20/2011 | WO2011009036A1 Soybean derived human thyroglobulin, methods of producing and applications thereof |
| 01/20/2011 | WO2011008970A1 Methods for diagnosing chronic diarrhea through protein secretion analysis |
| 01/20/2011 | WO2011008947A2 Treatment and diagnosis of immune disorders |
| 01/20/2011 | WO2011008942A2 Simultaneous quantitative multiple primer detection of clostridium difficile |
| 01/20/2011 | WO2011008912A1 Novel fluorescent dyes and uses thereof |
| 01/20/2011 | WO2011008850A2 H3k27me3 and cancer |
| 01/20/2011 | WO2011008814A2 Multiplexed measurement of exogenous and endogenous dna |
| 01/20/2011 | WO2011008769A2 Orthologous phenotypes and non-obvious human disease models |
| 01/20/2011 | WO2011008696A2 Diagnostic methods and compositions for treatment of cancer |
| 01/20/2011 | WO2011008682A1 Urinary trypsin inhibitors as diagnostic aid for interstitial cystitis |
| 01/20/2011 | WO2011008553A1 Rna sample stabilization in the presence of a transitional metal |
| 01/20/2011 | WO2011008541A2 Molecular markers and assay methods for characterizing cells |
| 01/20/2011 | WO2011008530A2 Chimeric primers with hairpin conformations and methods of using same |
| 01/20/2011 | WO2011008502A2 Isolation of unknown rearranged t-cell receptors from single cells |
| 01/20/2011 | WO2011008400A2 High-throughput complement-mediated antibody-dependent and opsonic bactericidal assays |
| 01/20/2011 | WO2011008349A2 Methods of identifying infectious disease and assays for identifying infectious disease |
| 01/20/2011 | WO2011008217A1 Methods and systems for dna isolation on a microfluidic device |
| 01/20/2011 | WO2011008173A1 Improved screening of biopolymers |
| 01/20/2011 | WO2011008171A1 Influenza detection method and kit therefor |
| 01/20/2011 | WO2011008030A2 Chromatographic system for nucleic acid detection |
| 01/20/2011 | WO2011007936A1 Diagnostic method for fetal neurological disorders due to maternal epilepsy and screening method for therapeutic agents therefor |
| 01/20/2011 | WO2011007889A1 Method for amplifying nucleic acid |
| 01/20/2011 | WO2011007876A1 Nucleic acid molecule capable of binding to hmgb1, and use thereof |
| 01/20/2011 | WO2011007815A1 Method for screening feed enabling the production of milk having immunomodulating effect |
| 01/20/2011 | WO2011007314A1 IMIDAZO[1,2-α]PYRAZIN-3(7H)-ONE DERIVATIVES BEARING A NEW ELECTRON-RICH STRUCTURE |
| 01/20/2011 | WO2011007244A1 Method for determining the sensitivity or resistance of retrovirus isolates to molecules, therapeutic retroviral treatments based on viral protease inhibitors and diagnostic kits |
| 01/20/2011 | WO2011007155A1 Screening method |
| 01/20/2011 | WO2011007131A1 Biomarker er2 for gynaecological cancer |
| 01/20/2011 | WO2011007013A1 Znf217 a new prognostic and predictive biomarker of recurrent, invasive and metastatic phenotypes in breast cancer |
| 01/20/2011 | WO2011006962A1 Nucleic acid expression construct and its use as a cell proliferation marker |
| 01/20/2011 | WO2011006911A2 Mass spectrometric diagnosis of septicemia |
| 01/20/2011 | WO2011006909A2 Marker sequences for adiposity |
| 01/20/2011 | WO2011006449A1 Retrotransposons of schistosoma japonicum and uses thereof |
| 01/20/2011 | WO2011006306A1 Nucleic acid fragments co-modified by both locked nucleic acid and minor groove binder |
| 01/20/2011 | WO2011006249A1 Mutated sumo isoforms and uses thereof |
| 01/20/2011 | WO2011006214A1 Method of detecting radiation exposure and adverse toxicity thereto |
| 01/20/2011 | WO2010132888A3 Methods and compositions relating to fusions of alk for diagnosing and treating cancer |
| 01/20/2011 | WO2010123354A3 Method of diagnosing bladder cancer |
| 01/20/2011 | WO2010115061A9 Biomarkers for monitoring treatment of neuropsychiatric diseases |
| 01/20/2011 | WO2010093209A3 Use of caveolin-1 as biomarker diagnosing wound healing ability after ophthalmological surgery and method for diagnosing wound healing ability using the same |
| 01/20/2011 | WO2010077859A3 Nucleic acid amplification and sequencing on a droplet actuator |
| 01/20/2011 | WO2010006177A9 Muc1, caspase-8,and ded-containing proteins |
| 01/20/2011 | WO2007043039A3 A catalytic biosensor |
| 01/20/2011 | WO2003034984A9 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 01/20/2011 | US20110016583 Drought tolerant plants and related constructs and methods involving genes encoding protein tyrosine phosphatases |
| 01/20/2011 | US20110016547 Use of regulatory sequences for specific, transient expression in neuronal determined cells |
| 01/20/2011 | US20110016538 Susceptibility locus for schizophrenia |
| 01/20/2011 | US20110016537 Cellular model of tauopathies for lead identification and drug discovery |
| 01/20/2011 | US20110015381 Instrument and method for collecting nucleic acids |
| 01/20/2011 | US20110015259 Tle3 as a marker for chemotherapy |
| 01/20/2011 | US20110015239 Inhibitors of calcium-activated chloride channels |
| 01/20/2011 | US20110015201 Hedgehog pathway antagonists and methods of use |
| 01/20/2011 | US20110015169 Methods for in vitro maturation of ovarian follicles |
| 01/20/2011 | US20110015136 humanized model of membrane attack complex (MAC) formation on murine retina and compositions, kits and methods for treatment of macular degeneration |
| 01/20/2011 | US20110015123 Modulation of GLUT4 Gene Promoter activity BY AHNAK |
| 01/20/2011 | US20110015095 Arachnocampa luciferases |
| 01/20/2011 | US20110015093 High throughput methods for functionally determining rna interference efficiency |
| 01/20/2011 | US20110015092 Markers for breast cancer |
| 01/20/2011 | US20110015090 Markers of Acute Myeloid Leukemia Stem Cells |
| 01/20/2011 | US20110015088 Biocatalytic solgel microarrays |
| 01/20/2011 | US20110015086 Programmable oligonucleotme micro array |
| 01/20/2011 | US20110015084 Methods for Identifying Genetic Linkage |
| 01/20/2011 | US20110015081 Genetic Variants on chr 5p12 and 10q26 as Markers for Use in Breast Cancer Risk Assessment, Diagnosis, Prognosis and Treatment |
| 01/20/2011 | US20110014646 Sample preparation apparatus and sample preparation method, and cell analyzer and cell analysis method |
| 01/20/2011 | US20110014645 Method for determining a complete blood count on a white blood cell differential count |
| 01/20/2011 | US20110014644 Methods for predicting a cancer patient's response to antifolate chemotherapy |
| 01/20/2011 | US20110014643 Neuronal Cells Cultured On Microparticles and Methods of Using Same |